The Journal of Headache and Pain is the official journal of the European Headache Federation and Lifting The Burden.
Galcanezumab in patients with episodic migraine: results from the open-label period of the phase 3 PERSIST study
The phase 3 randomized PERSIST study demonstrated the efficacy and tolerability of galcanezumab, a humanized anti-calcitonin gene-related peptide (CGRP) monoclonal antibody for prevention of episodic migraines...